9,532 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by MBB Public Markets I LLC

MBB Public Markets I LLC purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,532 shares of the company’s stock, valued at approximately $611,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. raised its position in shares of Henry Schein by 1.7% during the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock worth $1,165,425,000 after purchasing an additional 260,537 shares during the period. American Century Companies Inc. raised its holdings in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after buying an additional 162,477 shares during the last quarter. Swedbank AB bought a new position in shares of Henry Schein in the first quarter valued at $215,998,000. Fiduciary Management Inc. WI increased its position in shares of Henry Schein by 17.1% during the fourth quarter. Fiduciary Management Inc. WI now owns 2,284,337 shares of the company’s stock worth $172,947,000 after acquiring an additional 333,855 shares in the last quarter. Finally, Nuance Investments LLC raised its holdings in shares of Henry Schein by 6.2% in the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock worth $119,440,000 after acquiring an additional 108,143 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.3 %

Henry Schein stock opened at $71.94 on Wednesday. The firm has a 50 day moving average price of $70.14 and a 200-day moving average price of $70.17. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a market capitalization of $9.21 billion, a P/E ratio of 24.30, a P/E/G ratio of 2.01 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The business’s revenue was up .0% on a year-over-year basis. During the same period in the previous year, the company posted $1.31 earnings per share. As a group, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.14% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have issued reports on HSIC. Piper Sandler reiterated an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a report on Friday, September 20th. Robert W. Baird reduced their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Finally, Evercore ISI dropped their price target on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $77.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.